Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Lisata Therapeutics Q4 GAAP EPS $(0.55) Beats $(0.79) Estimate

Author: Benzinga Newsdesk | February 27, 2025 04:56pm
Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $(0.79) by 30.38 percent. This is a 16.67 percent increase over losses of $(0.66) per share from the same period last year.

Posted In: LSTA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist